Andrea Cossarizza and Stefano Salvioli
Department of Biomedical Sciences
University of Modena School of Medicine
via Campi 287, 41100 Modena, Italy
phone +39 59 428.613
fax +39 59 428.623
E mail: cossariz@unimo.it
Introduction
To detect variations in D y at the single cell or at the single organelle level, a few years ago we have developed a new cytofluorimetric (FCM) technique by using the lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1) (13-15). JC-1 is more advantageous over rhodamines and other carbocyanines, capable of entering selectively into mitochondria, since it changes reversibly its color from green to orange as membrane potentials increase (over values of about 80-100 mV). This property is due to the reversible formation of JC-1 aggregates upon membrane polarization that causes shifts in emitted light from 530 nm (i.e., emission of JC-1 monomeric form) to 590 nm (i.e., emission of J-aggregate) when excited at 490 nm; the color of the dye changes reversibly from green to greenish orange as the mitochondrial membrane becomes more polarized (16-18). Both colors can be detected using the filters commonly mounted in all flow cytometers, so that green emission can be analyzed in fluorescence channel 1 (FL1) and greenish orange emission in channel 2 (FL2). The main advantage of the use of JC-1 is that it can be both qualitative, considering the shift from green to orange fluorescence emission, and quantitative, considering the pure fluorescence intensity, which can be detected in both FL1 and FL2 channels.
Clearly, D y has been previously studied by flow cytometry, mostly by evaluating the changes in fluorescence intensity of cells stained with different, cationic dyes. Researchers used first Rh123 (19-21), then other molecules such as DiOC6(3) (22). Typically, the signal coming from cells whose mitochondria had a low potential was much lower than that of control samples, and in a classical histogram depolarized populations go to the left. However, after the shift to the left the peaks (i.e. that of controls and treated cells) are not always perfectly separate, the operator has to decide "by eye" where the population of cells with depolarized mitochondria begins. These two fluorescent probes have this and other problems. Rh123 binding to mitochondria is difficult to calculate when the cell has a certain mitochondrial heterogeneity due, for example, to a high number of mature or immature organelles, as occurs in a continuously growing cell line. Moreover, different mitochondrial binding sites for Rh123 exist, i.e. sites which are freely accessible whatever the energy status of the mitochondria and sites which are hidden in the energized state and freely accessible in the deenergized form of the organelle. This has been attributed to different maturative states of the organelles. Thus, in a single cell, organelles can have different Rh123 binding sites with consequent different fluorescence emissions. As a result, it is very difficult to ascertain whether or not mitochondria bind Rh123 in an energy-dependent or energy-independent manner. However, the probe is perfect when used in association with propidium iodide, as this combination allows a clear and elegant distinction between dead and living cells (4).
DiOC6(3) is more reliable for analysis of plasmamembrane potential rather than for studies on DY. Indeed, the first application of this probe in FCM was for the analysis of plasmamembrane potential (23). After this, DiOC6(3) was used in isolated mitochondria to detect D y changes (24). Any cationic molecule goes to negative sites, and can be released when the negative charge decreases. If that molecule is fluorescent, the signal decreases when the membrane potential of the organelle is lost. Fluorescent molecules present in intact cells have a different behaviour. In our hands, DiOC6(3) reacted properly when U937 cells were treated with FCCP, but such behaviour was not observed in cells treated with valinomycin. Moreover, when cells were kept in the presence of plasmamembrane depolarizing agents such as ouabain or high doses of extracellular K+, a consistent decrease in DiOC6(3) fluorescence was noted, indicating a consistent sensitivity of the probe for plasmamembrane (12). This behaviour was not totally unexpected, as it is known that this probe can bind several membranes other than mitochondria, as also reported in the Handbook of Fluorescent Probes and Research Chemicals (edited by the Company that produces and sells this reagent, i.e. Molecular Probes, Eugene, OR, USA). Thus, using this probe, it is very difficult, if not impossible, to distinguish between depolarization of plasmamembrane or changes in DY in several physiological or pathological conditions, such as apoptosis, when both events can take place.
2. Stain cell suspension with 2.5 mg/mL JC-1. Shake cell suspension until the dye is well dissolved, giving a uniform red-violet color. To do this, it is also possible to vortex vigorously the suspension immediately after the addition of the probe.
3. Keep the samples in a dark place at room temperature for 15-20 minutes. The duration of the staining depends upon the cell type, but in our hands all the cells used (lymphocytes, cell lines of different origin, fibroblasts, keratinocytes, hepatocytes, etc.) responded quite well to the treatment. Wash twice centrifuging at 500 g for 5 min with a double volume of PBS.
4. Resuspend in 0.3 mL of PBS, then analyze immediatly with the flow cytometer, typically equipped with a 488 nm argon laser. Set the value of photomultiplier (PMT) detecting the signal in FL1 at about 390 V, and FL2 PMT at 320 V; FL1-FL2 compensation should be around 4.0%, while FL2-FL1 compensation around 10.6%. This is however the classical setting of the instrument we use in our laboratory, and it has to be taken into account that, as each instrument has a different sensitivity, a different setting can be necessary to obtain an optimal signal. Concerning instruments, the staining has been tested on several different apparatus such as an Excel, from Coulter (in Bergen, Norway), an Elite (Coulter) in Paris, some FACSCAN, a FACSTAR Plus and a FACSCalibur, from Becton Dickinson (in Krakow, Poland, or Modena and Venice, Italy), a Biorad Brite and a Partec (in Krakow too), and they work perfectly as well. Obviously, compensations have to be set in a different way.
3. COMMENTARY
3.1 Background information
The technique of JC-1 staining has been developed with the intent to
detect DY in intact, viable cells. For this
purpose JC-1 acts as a marker of mitochondrial activity, since the formation
of J-aggregates, which give red emission, is reversible. Cells with high
DY are those forming J-aggregates, thus showing
high red fluorescence. On the other hand, cells with low
DY are those in which JC-1 maintains (or re-acquire) monomeric form,
thus showing only green fluorescence. Normally green fluorescence of depolarized
cells is a little bit higher than that of polarized ones simply because
of the presence of a higher amount of JC-1 monomers.
Staining procedure must be carried under no direct intense light and incubation in the dark, because the light sensitivity of JC-1.
Always wear gloves when handling JC-1.
The need of high DY for the formation of J-aggregates makes this staining not suitable for fixed samples. Indeed, this technique has to be considered as a functionality test. Possible disadvantages come from the wide emission spectrum of the dye, which occupies two fluorescence channels, thus avoiding the use of other probes conjugated with FITC (e.g. monoclonal antibodies). The coupling with probes emitting in deep red detectable in FL3 channel is theoretically possible, but has many problems in compensating the different fluorescences, depending on the particular emission spectrum of each probe (quenching phenomenon). In particular, using propidium iodide for assessing cell viability in cells labelled with JC-1 can create consistent problems.
Only recently can the Authors test the stability of the probe in living cells fixed after the staining. This was done because cells were infected with HIV-1, and it is strongly recommended to fix such cells before running them into a flow cytometer. A light fixation with 0.5% formaldeide (few minutes at room temperature) however does not change the fluorescence pattern.
1. Presence of fluorescent molecules other than JC-1 in the sample: analyze first a non stained sample and set the instrument on its spontaneus fluorescence, then analyze the stained samples with the same setting. See also point 3.2.
2. Cells are not well stained: increase the amount of JC-1. Try to stain with an incubation at 37°C instead at room temperature.
3. Cell are too much stained: decrease the amount of JC-1. Leave the cells to stay a little bit longer in the JC-1 free PBS in order to allow the dye to reach the appropiate distribution equilibrium.
4. Fluorescence pattern too much widespread: see point 3.4. Do not consider any event with a very high FL2 fluorescence: very often they are JC-1 aggregates. Increase FSC threshold and discard debris with electronic gating: the presence of stained debris or broken cells can constitute a confounding element in the whole fluorescence pattern.
3.4 Anticipated results
It is recommended to perform each experiment using a "positive control"
sample, in which mitochondria of all cells have been depolarized in order
to have a correct setting of the instrument. Treating cells with drugs
able to collapse DY, such as the K+ ionophor
valinomycin (100 nM or more) or the proton translocator carbonyl cyanide
p-(trifluoromethoxy) phenylhydrazone (FCCP, 250 nM), results in a dramatic
change of the fluorescence distribution that indicates where depolarized
cells have to go and helps a lot in setting the compensation. For problems
related to intracellular trafficking and drug neutralization, valinomycin
works much better than FCCP (and is also less expensive).
When the sample contains an heterogeneic cell population, it is possible to see different fluorescence patterns due to the variable content in membranes and mitochondria of cell subpopulations. It is typical the case of peripheral blood mononuclear cells (PBMC), formed by lymphocytes and monocytes, the first being smaller and with less mitochondrial content than the latter. Accordingly, the fluorescence pattern of JC-1 of such sample shows two distinct peaks, one corresponding to lymphocytes, and the second, brighter in both FL1 and FL2, corresponding to monocytes.
Another good control is that of mitochondrial mass, that can be done with nonyl acridine orange (NAO), that binds mitochondria independently of their energization state, and whose fluorescence is detectable in FL1. Typically, cells are incubated at the concentration of 0.5-1x106 cells/mL with 10 µM NAO (Molecular Probes) for 10 min. in the dark at room temperature, washed twice in cold PBS and immediately analyzed. The result you obtain gives you an idea of the mass of mitochondria present within a cell, and allows you to be sure that the changes you see with a potential-sensitive probe are not dependent upon the simple loss of organelles. It is easy to imagine that also in this case monocytes are brighter than lymphocytes.
3.5 Time considerations
The protocol of JC-1 staining does not require a long time (more or
less 30 minutes). The duration of the staining procedure can obviously
increase, depending on the number of samples to be analyzed.
3.6 Key references
2. Susin S.A., Zamzami N., Castedo M., Daugas E., Wang H.G., Geley S., Fassy F., Reed J.C., Kroemer G. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J. Exp. Med., 186: 25-37, 1997.
3. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med., 3: 614-620, 1997.
4. Cossarizza A., Kalashnikova G., Grassilli E., Chiappelli F., Salvioli S., Capri M., Barbieri D., Troiano L., Monti D., Franceschi C. Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level. Exp. Cell Res., 214: 323-330, 1994.
5. Richter C., Schweizer M., Cossarizza A., Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett., 378: 107-110, 1996.
6. Gorman A.M., Samali A., McGowan A.J., Cotter T.G. Use fo flow cytometry techniques in studying mechanisms of apoptosis in leukemic cells. Cytometry, 29: 97-105, 1997.
7. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science, 275: 1129-1132, 1997.
8. De Maria R., Lenti L., Malisan F., d'Agostino F., Tomassini B., Zeuner A., Rippo M.R., Testi R. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science, 277: 1652-1654, 1997.
9. Maftah A., Petit J.M., Ratinaud M.H.A.J., R. 10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem. Biophys. Res. Commun., 164: 185-190, 1989.
10. Lopez-Mediavilla C., Orfao A., Gonzales M., Medina J.M. Identification by flow cytometry of two distinct rhodamine-123-stained mitochondrial populations in rat liver. FEBS Lett., 254: 115-120, 1989.
11. Terasaki M., Song J., Wong J.R., Weiss M.J., Chen B.L. Localization of endoplasmic reticulum in living and glutaraldehyde-fixed cells with fluorescent dyes. Cell, 38: 101-108, 1984.
12. Salvioli S., Ardizzoni A., Franceschi C., Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess DY in intact cells. Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett., 411: 77-82, 1997.
13. Cossarizza A., Baccarani Contri M., Kalashnikova G., Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun., 197: 40-45, 1993.
14. Cossarizza A., Salvioli S., Franceschini M.G., Kalashnikova G., Barbieri D., Monti D., Grassilli E., Tropea F., Troiano L., Franceschi C. Mitochondria and apoptosis: a cytofluorimetric approach. Fund. Clin. Immunol., 3: 67-68, 1995.
15. Cossarizza A., Ceccarelli D., Masini A. Functional heterogeneity of isolated mitochondrial population revealed by cytofluorimetric analysis at the single organelle level. Exp. Cell Res., 222: 84-94, 1996.
16. Hada H., Honda C., Tanemura H. Spectroscopic study on the J-aggregate of cyanine dyes. I. Spectral changes of UV bands concerned with J-aggregate formation. Photogr. Sci. Eng., 21: 83-91, 1977.
17. Reers M., Smith T.W., Chen L.B. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry, 30: 4480-4486, 1991.
18. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., Steele G.D., Chen L.B. Intracellular heterogeneity in mitochondrial membrane potential revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA, 88: 3671-3675, 1991.
19. Johnson L.V., Walsh M.L., Bockus B.J., Chen L.B. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol., 88: 526-535, 1981.
20. Goldstein S., Korczack L.B. Status of mitochondria in living human fibroblasts during growth and senescence in vitro: use of the laser dye rhodamine 123. J. Cell Biol., 91: 392-398, 1981.
21. Darzynkiewicz Z., Staiano-Coico L., Melamed M.R. Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation. Proc. Natl. Acad. Sci. USA, 78: 2383-2387, 1981.
22. Petit P.X., Lecoeur H., Zorn E., Dauguet C., Mignotte B., Gougeon M.-L. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol., 130: 157-167, 1995.
23. Jenssen H.-L., Redmann K., Mix E. Flow cytometric estimation of transmembrane potential of macrophages - A comparison with microelectrode measurements. Cytometry, 7: 339-346, 1986.
24. Petit P.X., O'Connor D., Grunwald D., Brown S.C. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur. J. Biochem., 194: 389-397, 1990.
JC-1 is dissolved in N,N’-dimethylformamide (Sigma-Aldrich, cat. n. D8654) at the concentration of 2.5 mg/ml.
It is stored at -20°C. Light sensitive.
Appendix 2: Reagents
JC-1
Molecular Probes, Eugene, OR, USA |
catalog No.: T-3168 |
Note: colture medium, saline solutions and washing buffers are depending on the cell type which is used for the experimental procedure (PBMC, fibroblasts, hepatocytes, etc.). For blood white cells, RPMI 1640 with 10% heat inactivated foetal calf serum, 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine is normally used as complete colture medium.
Appendix 3: Equipment
Flow Cabinet TC60 | Gelaire |
Flow Cytometer FACScan | Becton Dickinson |
Incubator CO2-AUTO-ZERO | Heraeus |
Centrifuge Minifuge RF | Heraeus |
Pipetman P20, P200, P1000 | Gilson |
Vortex Vibrofix VF1 Electronic | Janke & Kunkel-Ika
Labortechnik |
Appendix 4: Glossary
Mitochondrial membrane potential (Dy) is generated by mitochondrial electron transport chain, which drives a proton flow from matrix through inner mitochondrial membrane to cytoplasm, thus creating an electrochemical gradient. This gradient is in turn responsible for the formation of ATP molecules by F0-F1 ATP synthase. For this reason Dy is an important parameter for mitochondrial functionality and an indirect evidence of energy status of the cell.